Neurochem Res 42 , 16611675 (2017)
Its primary licensed indication in the United States, under the brand name Egrifta is the reduction of excess visceral adipose tissue (VAT) in people living with HIV-associated lipodystrophy
Journal of cardiovascular translational research
Most human study data does start on a lower dose of 100 to 200 milligrams of NMN, slowly working up to 500 milligrams, according to Jillian Robillard, MS, RD, LDN
Populations needing medical oversight: chronic kidney disease, seizure disorders, pregnancy/lactation
Detoxification : It plays a vital role in detoxifying harmful substances, including heavy metals and pollutants, by conjugating with them to facilitate their excretion from the body